When tumor contact reshapes CAR-T cells

Area of Science:

• Immunology
• Cell Biology
• Cancer Therapy

Background:

• Chimeric antigen receptor (CAR)-T cell therapy shows promise in cancer treatment.
• CAR-T cell function can be impaired by chronic antigen exposure, a phenomenon not fully understood.
• Tumor microenvironment interactions are critical for CAR-T cell persistence and efficacy.

Purpose of the Study:

• To investigate the mechanisms by which chronic antigen exposure affects CAR-T cell function.
• To elucidate the role of endocytosis in CAR-T cell responses to repeated tumor contact.
• To understand how antigen accumulation impacts CAR-T cell viability and cytotoxic activity.

Main Methods:

• Utilized in vitro models of CAR-T cell-tumor cell interactions.
• Assessed CAR-T cell function, including antigen recognition and cytotoxicity.
• Investigated endocytic pathways, specifically Rab5-dependent processes, using microscopy and biochemical assays.
• Quantified trogocytosis and CAR expression levels.

Main Results:

• Repeated tumor contact led to impaired Rab5-dependent endocytosis in CAR-T cells.
• Accumulation of trogocytosed antigen was observed due to the impaired endocytic program.
• Functional CAR levels declined following chronic antigen exposure.
• Increased CAR-T cell fratricide was noted in conditions of repeated tumor contact.

Conclusions:

• Chronic antigen exposure disrupts essential CAR-T cell endocytic programs.
• Impaired endocytosis contributes to CAR-T cell dysfunction and reduced therapeutic efficacy.
• These findings highlight novel mechanisms of CAR-T cell exhaustion beyond simple exhaustion, offering targets for improving CAR-T cell therapy.